ONCOlog Medical partner IBA wins a tender that includes their PatLog system

LinkMed’s portfolio company ONCOlog Medical partner IBA has received an order for their proton therapy equipment from the Federal Medico-Biological Agency in Russia (FMBA of Russia). The order includes a fully PatLog® system and it will be the first gantry-equipped Proton Therapy center installed in Russia. Order value for ONCOlog Medical is circa SEK 10 million.

IBA won a public tender and will deliver the proton therapy equipment including PatLog® system from ONCOlog Medical to Federal High-Tech Medical Center in Dimitrovgrad, Russia.

The choice of PatLog® is a result of a successful cooperation between IBA and ONCOlog Medical which has resulted in several winning tenders.

The novel PatLog® approach of out-of-treatment room set up and smooth transportation of the patient between different imaging devices and treatment rooms, will highly improve the patient throughput in large radiotherapy clinics, at the same time as the treatment accuracy, patient comfort and clinical efficiency will be better.

About ONCOlog Medical
ONCOlog Medical is dedicated to innovative solutions in Radiation Therapy. The company mission is to bring Better Radiotherapy to More People by improved Accuracy, Comfort and Efficiency in Cancer care. The company was founded in 2002 and is owned by SLS Invest, LinkMed AB and the founders. Read more about ONCOlog Medical at
www.oncologmedical.com

For more information please contact:
Göran Beijer, VD, tel +46 18-19 45 65
goran.beijer@oncologmedical.com

LinkMed has two business areas, a commercial transplantation sector business with two subsidiaries and a venture portfolio comprising life science companies. The venture companies, all of which are associated companies, consist of four companies in drug development and biotechnology and six companies in diagnostics and medical technology. LinkMed is listed on NASDAQ OMX Stockholm, in the Small Cap sector (ticker symbol: LMED).

About Us

LinkMed, in collaboration with innovators, develops new life science companies. By contributing entrepreneurship and capital, LinkMed has created a portfolio of eleven companies, six in biotechnology and five in medical technology. The LinkMed share is listed on the OMX Nordic Exchange Stockholm in the small-cap sector (ticker:LMED). The company’s largest owners are FastPartner, Koncentra Holding, and the founder Ingemar Lagerlöf. See www.linkmed.se for more information.

Subscribe

Documents & Links